Wegovy could reduce the risk of adverse cardiovascular events by 20%, marking an ‘important step forward’ in tackling the consequences of obesity
New data found an 18% increase in cases of non-diabetic hyperglycaemia or pre-diabetes in 2023 compared to 2022, which is an ‘ever increasing challenge for the NHS’
The warning was issued after people were found to misuse anti-obesity drugs to get ‘beach body’ ready for summer, leading to ‘dangerous consequences’
Tirzepatide, a type-2 diabetes drug has been recommended as a treatment for obesity to help patients 'live longer and healthier lives'
Almost 168,000 people under 40 are living with the condition in the UK, reflecting a ‘troubling growing trend’ of serious health conditions in young people
Excess sugar intake is linked to tooth decay and increases the risk of weight gain which can mean a higher likelihood of living with overweight, obesity, and type 2 diabetes. We, as a population from...
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
